| Palmetto Vision Care Llc | |
|
88 Folly Road Blvd, Charleston, SC 29407-7551 | |
| (843) 573-9944 | |
| (843) 573-9969 |
| Full Name | Palmetto Vision Care Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 88 Folly Road Blvd, Charleston, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326243924 | NPI | - | NPPES |
| U952847884 | Other | SC | INSTILL HEALTH INSURANCE |
| 922 | Other | SC | BLUE CHOICE HEALTH PLAN |
| E1473 | Other | SC | MEDCOST |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1261 (South Carolina) | Primary |
| Provider Name | Michael Zan Morabito |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1265495220 PECOS PAC ID: 9830184803 Enrollment ID: I20040419000745 |
News Archive
The TriZetto Group, Inc. today announced the general availability of its Value-Based Benefits Solution, health benefits administration and incentive management software that enables healthcare payers to customize benefits and provide incentives for individual members based on their health status, chronic conditions, and health and wellness activity.
Ten African scientists have been selected for training at the National Institutes of Health as part of a new fellowship program to build research capacity in African countries and develop ongoing scientific partnerships.
Roche/Genentech/Chugai's pertuzumab plus trastuzumab (Roche/Genentech/Chugai's Herceptin) and docetaxel (Sanofi's Taxotere, generics) will become Decision Resources' proprietary clinical gold-standard treatment for metastatic first-line HER2-positive breast cancer in 2015.
In the meantime, programs in Missouri and Minnesota are being held up as examples of how provisions of the health law could unfold across the nation.
› Verified 2 days ago
| Provider Name | Matthew Blair Mccoy |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1063854610 PECOS PAC ID: 3678708674 Enrollment ID: I20131029000968 |
News Archive
The TriZetto Group, Inc. today announced the general availability of its Value-Based Benefits Solution, health benefits administration and incentive management software that enables healthcare payers to customize benefits and provide incentives for individual members based on their health status, chronic conditions, and health and wellness activity.
Ten African scientists have been selected for training at the National Institutes of Health as part of a new fellowship program to build research capacity in African countries and develop ongoing scientific partnerships.
Roche/Genentech/Chugai's pertuzumab plus trastuzumab (Roche/Genentech/Chugai's Herceptin) and docetaxel (Sanofi's Taxotere, generics) will become Decision Resources' proprietary clinical gold-standard treatment for metastatic first-line HER2-positive breast cancer in 2015.
In the meantime, programs in Missouri and Minnesota are being held up as examples of how provisions of the health law could unfold across the nation.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Palmetto Vision Care Llc 88 Folly Road Blvd, Charleston, SC 29407-7551 Ph: (843) 573-9944 | Palmetto Vision Care Llc 88 Folly Road Blvd, Charleston, SC 29407-7551 Ph: (843) 573-9944 |
News Archive
The TriZetto Group, Inc. today announced the general availability of its Value-Based Benefits Solution, health benefits administration and incentive management software that enables healthcare payers to customize benefits and provide incentives for individual members based on their health status, chronic conditions, and health and wellness activity.
Ten African scientists have been selected for training at the National Institutes of Health as part of a new fellowship program to build research capacity in African countries and develop ongoing scientific partnerships.
Roche/Genentech/Chugai's pertuzumab plus trastuzumab (Roche/Genentech/Chugai's Herceptin) and docetaxel (Sanofi's Taxotere, generics) will become Decision Resources' proprietary clinical gold-standard treatment for metastatic first-line HER2-positive breast cancer in 2015.
In the meantime, programs in Missouri and Minnesota are being held up as examples of how provisions of the health law could unfold across the nation.
› Verified 2 days ago
Robert J Black, OD Optometrist Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Coastal Eye Care Of Charleston, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1606 Harbor View Rd, Charleston, SC 29412 Phone: 843-795-3937 Fax: 843-795-4760 | |
Dr. Summer Moorer Paulatos, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1231 Folly Rd, Charleston, SC 29412 Phone: 843-795-3400 Fax: 843-795-3435 | |
Dr. Paul M Beranek, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1890 Sam Rittenberg Blvd Ste 107, Charleston, SC 29407 Phone: 843-763-2020 Fax: 843-763-2021 | |
Jackson Davenport Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 379 King St, Charleston, SC 29401 Phone: 843-722-4416 Fax: 843-720-8984 | |
Crescent Eye Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 3050 Ashley Town Center Dr, Charleston, SC 29414 Phone: 843-460-2000 Fax: 843-460-2022 | |
National Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2031 Sam Rittenberg Blvd Ste 101, Charleston, SC 29407 Phone: 843-867-7056 |